<DOC>
	<DOCNO>NCT00128544</DOCNO>
	<brief_summary>This study conduct compare effectiveness combination valtorcitabine telbivudine telbivudine alone patient chronic hepatitis B .</brief_summary>
	<brief_title>Telbivudine Versus Combination Telbivudine Valtorcitabine Patients With Chronic Hepatitis B</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Telbivudine</mesh_term>
	<criteria>Clinical history compatible compensate chronic hepatitis B Other protocoldefined inclusion criterion may apply . Patient pregnant breastfeeding Patient coinfected hepatitis C virus , hepatitis D virus HIV Patient previously receive lamivudine , adefovir dipivoxil investigational antihepatitis B virus ( HBV ) nucleoside nucleotide anytime . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>